Publications by authors named "Yotaro Numachi"

Claim this Profile
E
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis.
Shigekazu Kitamura, Takao Takeshima, Daishi Yui, Gabriel Paiva da Silva Lima, Reija Koukakis, Yotaro Numachi

Neurol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial.
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, Yotaro Numachi, Ryuji Yoshida

BMJ Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies.
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, Noboru Imai, Yasuhiko Matsumori, Yotaro Numachi

Brain Behav· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.
Koichi Hirata, Fumihiko Sakai, Takao Takeshima, Noboru Imai, Yasuhiko Matsumori, Yotaro Numachi

J Headache Pain· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine.
Fumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, Koichi Hirata, Sunfa Cheng, Yotaro Numachi

Headache· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat.
Masanori Yamada, Minori Osamura, Hirofumi Ogura, Tomohiro Onoue, Akira Wakamatsu, Yotaro Numachi

Clin Pharmacol Drug Dev· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Pyrimethamine in Healthy Male Subjects of Japanese and European Ancestry.
Takayuki Iida, Romina A Nand, Hiroko Ino, Hirofumi Ogura, Hiroshi Itoh, Yotaro Numachi

Clin Pharmacol Drug Dev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants.
Takayuki Iida, Yuki Matsuzawa, Hirofumi Ogura, Takashi Nagakubo, Akira Wakamatsu, Yotaro Numachi

Clin Pharmacol Drug Dev· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers.
Hiroko Ino, Akira Endo, Akira Wakamatsu, Hirofumi Ogura, Yotaro Numachi

Clin Pharmacol Drug Dev· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects.
Hiroko Ino, Robert Wilson, Takumi Terao, Hirofumi Ogura, Harue Igarashi, Yotaro Numachi

Clin Pharmacol Drug Dev· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of lamotrigine monotherapy in Japanese and South Korean pediatric patients with newly diagnosed typical absence seizures: An open-label extension study.
Sawa Yasumoto, Yoko Ohtsuka, Katsuaki Sato, Atsuyo Kurata, Yotaro Numachi

Brain Dev· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Bioequivalence Between 0.5-mg Dutasteride Capsules Manufactured by GlaxoSmithKline and an Existing Formulation: A Randomized Study in Healthy Japanese Male Volunteers.
Hiroko Ino, Hiroshi Itoh, Yohei Doi, Harue Igarashi, Yotaro Numachi

Clin Pharmacol Drug Dev· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of ropinirole controlled-release formulation at 18-24 mg/day in Japanese patients with Parkinson's disease.
Nobutaka Hattori, Kazuko Hasegawa, Katsuaki Sato, Erika Mitsuyama, Yotaro Numachi

Parkinsonism Relat Disord· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamotrigine monotherapy for newly diagnosed typical absence seizures in children: A multi-center, uncontrolled, open-label study.
Sawa Yasumoto, Masahiro Shimizu, Katsuaki Sato, Atsuyo Kurata, Yotaro Numachi

Brain Dev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontal and right temporal activations correlate negatively with depression severity during verbal fluency task: a multi-channel near-infrared spectroscopy study.
Takamasa Noda, Sumiko Yoshida, Taro Matsuda, Nagahisa Okamoto, Kota Sakamoto, Yotaro Numachi

J Psychiatr Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genetically modified animals as models for psychiatric diseases].
Ichiro Sora, Hideaki Kobayashi, Yotaro Numachi

Seishin Shinkeigaku Zasshi· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Survey on the abuse of uncontrolled drugs by using the Internet].
Yoshihisa Ohara, Yotaro Numachi, Hideaki Kobayashi, Motoyasu Yamashita, Hidekazu Watanabe

Nihon Shinkei Seishin Yakurigaku Zasshi· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis